Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T19:53:00.120Z.
Calculation as of: 2026-10-06T19:53:00.120Z.
Quote observation: 2026-10-06T19:50:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5a8aae8e93f82a899e51ff603ce0499f2ee8a4244ac8b174beef8711f00adb15
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Market Cap
$53.12M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$52.60M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$53.71M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.99M
EV/EBITDA Ratio
N/A
TTM Avg
335.70x
3Y Avg
335.70x
5Y Avg
335.70x
Market Cap
$50.66M
EV/EBITDA Ratio
N/A
TTM Avg
0.76x
3Y Avg
0.97x
5Y Avg
0.97x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spectral AI, Inc. (MDAI) | $52.99M | N/A | N/A | N/A | N/A |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.12M | N/A | N/A | N/A | N/A |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | N/A | N/A | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $53.71M | N/A | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.98M | N/A | N/A | N/A | N/A |
| Aldeyra The (ALDX)vs › | $54.46M | N/A | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $51.43M | N/A | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.99M | N/A | 335.70x | 335.70x | 335.70x |
| Tenax Therapeutics, Inc. (TENX)vs › | $50.66M | N/A | 0.76x | 0.97x | 0.97x |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.00M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
